Bronchiolitis Obliterans Overview

Save information for later
Sign Up

Learn About Bronchiolitis Obliterans

What is the definition of Bronchiolitis Obliterans?
Bronchiolitis obliterans is an inflammatory condition that affects the lung's tiniest airways, the bronchioles. In affected people, the bronchioles may become damaged and inflamed leading to extensive scarring that blocks the airways. Symptoms of the condition include a dry cough; shortness of breath; and/or fatigue and wheezing in the absence of a cold or asthma. Many different chemicals (such as nitrogen oxides, ammonia, welding fumes or food flavoring fumes) and respiratory infections can cause lung injury that leads to Bronchiolitis obliterans. It can also be associated with rheumatoid arthritis and graft-versus-host disease following a lung or hematopoietic cell transplantation. Another similarly named disease, Bronchiolitis obliterans organizing pneumonia, is a different disease.
What are the alternative names for Bronchiolitis Obliterans?
  • Bronchiolitis obliterans
  • Obliterative bronchiolitis
Who are the top Bronchiolitis Obliterans Local Doctors?
Dr. John E. Blanzy
Family Medicine
Dr. John E. Blanzy
Family Medicine

Oakwood Ambulatory LLC

14319 Dix Toledo Rd, 
Southgate, MI 
 (0.9 mi)
734-285-0677
Languages Spoken:
English
See accepted insurances
Accepting New Patients

John Blanzy is a Family Medicine provider in Southgate, Michigan. Dr. Blanzy and is rated as an Experienced provider by MediFind in the treatment of Bronchiolitis Obliterans. His top areas of expertise are Lipogranulomatosis, Lipoid Proteinosis, Bronchiolitis Obliterans, and Industrial Bronchitis. Dr. Blanzy is currently accepting new patients.

Dr. Maath J. Alani
Internal Medicine
Dr. Maath J. Alani
Internal Medicine

Ghassan A Atto MD PLLC

2333 Biddle Ave, Suite 8, 
Wyandotte, MI 
 (2.4 mi)
734-246-5500
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Maath Alani is an Internal Medicine provider in Wyandotte, Michigan. Dr. Alani and is rated as an Experienced provider by MediFind in the treatment of Bronchiolitis Obliterans. His top areas of expertise are COVID-19, Multisystem Inflammatory Syndrome in Children (MIS-C), Necrosis, Gastrostomy, and Endoscopy. Dr. Alani is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Dr. Ghassan A. Atto
Family Medicine
Dr. Ghassan A. Atto
Family Medicine

Ghassan A Atto MD PLLC

14825 Southfield Rd, 
Allen Park, MI 
 (3.0 mi)
313-383-7071
Languages Spoken:
English, Arabic
See accepted insurances
Accepting New Patients

Ghassan Atto is a Family Medicine provider in Allen Park, Michigan. Dr. Atto and is rated as an Experienced provider by MediFind in the treatment of Bronchiolitis Obliterans. His top areas of expertise are Necrosis, Peptic Ulcer, Sepsis, Gastrostomy, and Endoscopy. Dr. Atto is currently accepting new patients.

View All Doctors
What are the latest Bronchiolitis Obliterans Clinical Trials?
Nintedanib in Patients With Bronchiolitis Obliterans Syndrome Following Hematopoietic Stem Cell Transplantation (HSCT)- a Multicentre Phase II Trial
Nintedanib in Patients With Bronchiolitis Obliterans Syndrome Following Hematopoietic Stem Cell Transplantation (HSCT)- a Multicentre Phase II Trial
Who is this study for: Patients with Bronchiolitis Obliterans
Enrollment Status: Recruiting
Publish Date: February 19, 2025
Intervention Type: Drug
Study Drug: Nintedanib
Study Phase: Phase 2

Summary: This study investigates the safety and tolerability of Nintedanib in patients with bronchiolitis obliterans syndrome (BOS) following allogeneic hematopoietic cell transplantation. All study patients with BOS will be treated with the study drug Nintedanib (300 mg/day) as an add-on therapy to their basic immunosuppressive treatment over a 12-months treatment period.

Match to trials
Find the right clinical trials for you in under a minute
Get started
Hyperpolarized 129-Xenon Imaging in Adult Hematopoietic Cell Transplant Recipients With Pulmonary Impairment
Hyperpolarized 129-Xenon Imaging in Adult Hematopoietic Cell Transplant Recipients With Pulmonary Impairment
Enrollment Status: Recruiting
Publish Date: February 18, 2025
Intervention Type: Device

Summary: This study is designed to measure the correlation of hyperpolarized 129-Xe magnetic resonance imaging (129-XeMRI) in allogeneic hematopoietic cell transplant (allo-HCT) recipients at MD Anderson Cancer Center (MDACC) who develop bronchiolitis obliterans syndrome (BOS) or BOS stage 0p (pulmonary impairment not meeting the definition for BOS, defined below) and controls with chronic graft-versus-hos...

View All Clinical Trials
Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center